ExodusPoint Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-400
Closed -$354K 1806
2024
Q3
$354K Sell
400
-3,800
-90% -$3.42M ﹤0.01% 1306
2024
Q2
$3.81M Sell
4,200
-3,800
-48% -$3.04M 0.03% 512
2024
Q1
$6.21M Sell
8,000
-205,200
-96% -$146M 0.05% 330
2023
Q4
$124M Buy
+213,200
New +$124M 0.82% 19

Other funds holding LLY

ExodusPoint Capital Management's LLY Position: Q1 2026 in Review

ExodusPoint Capital Management opened a new position in Eli Lilly (LLY) in Q1 2026: 25,699 shares worth $23.6M. The stake represents 0.19% of the portfolio and ranks #76 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in LLY as recently as Q2 2025.

ExodusPoint Capital Management first reported a position in LLY in Q4 2018 and has held it in 16 quarters since. The position peaked at $28.2M in Q2 2022. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • ExodusPoint Capital Management held 25,699 shares of Eli Lilly worth $23.6M as of Q1 2026.
  • Eli Lilly was a new ExodusPoint Capital Management position in Q1 2026.
  • Eli Lilly made up 0.19% of ExodusPoint Capital Management's portfolio in Q1 2026, its #76 holding.
  • ExodusPoint Capital Management first reported a position in Eli Lilly in Q4 2018 and has held it in 16 quarters since.
  • ExodusPoint Capital Management's Eli Lilly position peaked at $28.2M in Q2 2022.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.